Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cathy Prescott Insider Profile
4 Followers
Cathy Prescott, Director at SkinBioTherapeutics, holds 181.11K shares in SkinBioTherapeutics (Ticker: GB:SBTX). Most recently, Cathy Prescott Bought 62,500p shares of SkinBioTherapeutics on Dec 16, 2022 for an estimated value of 10.00K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+64.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Cathy Prescott holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 14, 2020 - Oct 14, 2021
Return:+245.80%
The most profitable trade made by Cathy Prescott
Cathy Prescott's Trading History
List of latest transactions for each holding click on a transaction to see Cathy Prescott's performance on stock
You May Also Like
Cathy Prescott insider profile FAQ
What is the percentage of profitable transactions made by Cathy Prescott?
The percentage of profitable transactions made by Cathy Prescott is 33%.
What is the average return per transaction made by Cathy Prescott?
The average return per transaction made by Cathy Prescott is 64.30%.
What stocks does Cathy Prescott hold?
Cathy Prescott holds: GB:SBTX stocks.
What was Cathy Prescott’s latest transaction?
Cathy Prescott latest transaction was an Informative Buy of 10.00K.
What was Cathy Prescott's most profitable transaction?
Cathy Prescott’s most profitable transaction was an Informative Buy of GB:SBTX stock on October 14, 2020. The return on the trade was 245.80%.
What is Cathy Prescott's role in SkinBioTherapeutics?
Cathy Prescott's role in SkinBioTherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.